Warner Chilcott Takes Aim At Lupin's Generic Generess Fe
According to the suit, Lupin notified Warner Chilcott in October of its plans for a generic version of the contraceptive.
Warner Chilcott claims Lupin's abbreviated new drug application infringes its patent. It is seeking a court order that Lupin will not be able to market its generic version until the expiration date of the patent, which...
To view the full article, register now.